JP2003119135A - 血行改善薬 - Google Patents

血行改善薬

Info

Publication number
JP2003119135A
JP2003119135A JP2001314228A JP2001314228A JP2003119135A JP 2003119135 A JP2003119135 A JP 2003119135A JP 2001314228 A JP2001314228 A JP 2001314228A JP 2001314228 A JP2001314228 A JP 2001314228A JP 2003119135 A JP2003119135 A JP 2003119135A
Authority
JP
Japan
Prior art keywords
blood circulation
vitamin
agent
tocopherol
drug
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2001314228A
Other languages
English (en)
Japanese (ja)
Other versions
JP2003119135A5 (https=
Inventor
Minoru Okada
実 岡田
Yoshioki Suehiro
義興 末廣
Hirotaka Sakai
裕貴 坂井
Katsumi Imamori
勝美 今森
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
SSP Co Ltd
Original Assignee
SSP Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by SSP Co Ltd filed Critical SSP Co Ltd
Priority to JP2001314228A priority Critical patent/JP2003119135A/ja
Priority to TW091119274A priority patent/TWI262074B/zh
Priority to CNB021439826A priority patent/CN1230172C/zh
Priority to KR1020020059691A priority patent/KR20030030867A/ko
Publication of JP2003119135A publication Critical patent/JP2003119135A/ja
Priority to HK03107058.1A priority patent/HK1054696B/xx
Publication of JP2003119135A5 publication Critical patent/JP2003119135A5/ja
Pending legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/35—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom
    • A61K31/352—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom condensed with carbocyclic rings, e.g. methantheline 
    • A61K31/353—3,4-Dihydrobenzopyrans, e.g. chroman, catechin
    • A61K31/355—Tocopherols, e.g. vitamin E
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/455—Nicotinic acids, e.g. niacin; Derivatives thereof, e.g. esters, amides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Pyridine Compounds (AREA)
  • Pyrane Compounds (AREA)
  • Medicinal Preparation (AREA)
JP2001314228A 2001-10-11 2001-10-11 血行改善薬 Pending JP2003119135A (ja)

Priority Applications (5)

Application Number Priority Date Filing Date Title
JP2001314228A JP2003119135A (ja) 2001-10-11 2001-10-11 血行改善薬
TW091119274A TWI262074B (en) 2001-10-11 2002-08-26 Blood circulation improving preparation
CNB021439826A CN1230172C (zh) 2001-10-11 2002-09-29 血液循环改善剂
KR1020020059691A KR20030030867A (ko) 2001-10-11 2002-10-01 혈행 개선약
HK03107058.1A HK1054696B (en) 2001-10-11 2003-09-30 Blood circulation improving preparation

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP2001314228A JP2003119135A (ja) 2001-10-11 2001-10-11 血行改善薬

Publications (2)

Publication Number Publication Date
JP2003119135A true JP2003119135A (ja) 2003-04-23
JP2003119135A5 JP2003119135A5 (https=) 2005-06-09

Family

ID=19132579

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2001314228A Pending JP2003119135A (ja) 2001-10-11 2001-10-11 血行改善薬

Country Status (4)

Country Link
JP (1) JP2003119135A (https=)
KR (1) KR20030030867A (https=)
CN (1) CN1230172C (https=)
TW (1) TWI262074B (https=)

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4612194A (en) * 1984-02-15 1986-09-16 Roshdy Ismail Anti-rheumatic agents and their use
JPS61277609A (ja) * 1985-06-01 1986-12-08 Mikasa Kagaku Kogyo Kk 入浴剤
JPS62123108A (ja) * 1985-11-21 1987-06-04 Kanebo Ltd 養毛化粧料
JPS62123105A (ja) * 1985-11-21 1987-06-04 Kanebo Ltd 皮膚化粧料
KR930019221A (ko) * 1992-03-02 1993-10-18 이승철 성인병 예방 및 치료용 순환계용계약 조성물
US5811547A (en) * 1992-10-14 1998-09-22 Nippon Shinyaju Co., Ltd. Method for inducing crystalline state transition in medicinal substance

Also Published As

Publication number Publication date
HK1054696A1 (en) 2003-12-12
CN1411811A (zh) 2003-04-23
TWI262074B (en) 2006-09-21
KR20030030867A (ko) 2003-04-18
CN1230172C (zh) 2005-12-07

Similar Documents

Publication Publication Date Title
KR20010030798A (ko) 경구 투여 제제
ITFI970184A1 (it) Composizioni farmaceutiche contenenti vitamina d e calcio,loro preparazione ed uso terapeutico
EP0354973A1 (en) Drug delivery system
JP2008508305A (ja) 栄養補充のための組成物および方法
KR0178033B1 (ko) 고혈압 치료용 조성물
KR20070032752A (ko) 비타민 제제
JP3135273B2 (ja) 保存安定性硫酸グルコースアミン経口薬剤とその製造方法
JP2001515486A (ja) ビタミンｄ３及びトリカルシウムフォスフェートを含有する安定な固形製剤
WO1991014429A1 (en) Pharmaceutical compositions containing ipriflavone, process for the preparation thereof and relative therapeutic use
JP2001097856A (ja) 鎮咳剤
JP2003119135A (ja) 血行改善薬
KR100740079B1 (ko) 당뇨병성 신경 장해용 의약 조성물
JP5801540B2 (ja) 医薬組成物
JP5576006B2 (ja) １日２回服用型経口投与製剤
JP2011068647A (ja) アスパラギン酸又はその塩含有固形製剤
JPH04287660A (ja) フッ素症を予防する組成物とその方法
JP2005325070A (ja) 睡眠改善剤
JP5345786B2 (ja) 睡眠改善組成物
TWI244921B (en) Oral administration medicine with improving absorbability
JPH05294833A (ja) ビタミン含有保健剤
JP2001122788A (ja) 医薬用固形組成物
WO1987000428A1 (en) Oxazepam containing pharmaceutical composition
HK1054696B (en) Blood circulation improving preparation
JP2023148072A (ja) 暑熱ストレス緩和剤
JPH11335280A (ja) 経口固形製剤

Legal Events

Date Code Title Description
A521 Written amendment

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20040907

A621 Written request for application examination

Free format text: JAPANESE INTERMEDIATE CODE: A621

Effective date: 20040907

A131 Notification of reasons for refusal

Free format text: JAPANESE INTERMEDIATE CODE: A131

Effective date: 20080527

A02 Decision of refusal

Free format text: JAPANESE INTERMEDIATE CODE: A02

Effective date: 20081028